secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2025-07-11T23:59:59+00:00
Accession:  0000950170-25-095296
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Corleen Roche resigns effective Aug 5; Robert Lapetina named interim principal financial officer
--------------------------------------------------------------------------------

- CFO Corleen Roche resigns effective August 5, 2025.
- Robert Lapetina, VP FP&A since May 2024, appointed interim principal financial and accounting officer.
- Lapetina previously VP Finance and Controller at Immunome, Inc. and roles at Chubb, Teleflex, Pfizer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000095017025095296/0000950170-25-095296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000095017025095296/ck0001991792-20250707.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-095296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer